Načítá se...
A synopsis of recent developments defining how N-glycosylation impacts immunoglobulin G structure and function
Therapeutic monoclonal antibodies (mAbs) are the fastest growing group of drugs with 11 new antibodies or antibody-drug conjugates approved by the Food and Drug Administration in 2018. Many mAbs require effector function for efficacy, including antibody-dependent cell-mediated cytotoxicity triggered...
Uloženo v:
| Vydáno v: | Glycobiology |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7109350/ https://ncbi.nlm.nih.gov/pubmed/31822882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/glycob/cwz068 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|